Tristel plc
("Tristel" or "the Company")
Proposed Secondary Placing
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that certain directors intend to sell up to 3,329,371 ordinary shares of 1 penny each in the capital of the Company (the "Placing Shares" and the "Placing"), representing approximately 7.84% of the issued share capital of the Company at a price of 175 pence per Placing Share in order to satisfy market demand and broaden the institutional shareholder base of the Company. The Board also confirms that its expectations for the Company's full year performance remain consistent with its statement dated 23 February 2017.
The completion of the Placing and the resulting directors' shareholdings will be announced as soon as practicable.
The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.
For further information please contact:
Tristel plc |
Tel: 01638 721 500 |
Paul Swinney, Chief Executive Officer |
|
Liz Dixon, Finance Director |
|
|
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or tristel@walbrookpr.com |
Paul McManus |
Mob: 07980 541 893 |
Lianne Cawthorne |
Mob: 07854 391 303 |
|
|
finnCap |
Tel: 020 7220 0500 |
Geoff Nash (Corporate Finance) |
|
Giles Rolls (Corporate Finance) |
|
Alice Lane (Corporate Broking) |
|